Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KINETA, INC./DEYMTX · Entity 77778 | Director | June 02, 2021 | June 04, 2021 |
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Director | May 12, 2017 | May 16, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KINETA, INC./DE
Report date June 02, 2021 · Filed June 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.26 · Expires 2031-06-01 | Direct | 14,800 |
Reported balance
After 2021-06-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-02 · Grant · Acquired 14,800 · Balance 14,800 F1: The shares subject to the option shall vest in equal quarterly installments over three years following June 2, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option shall vest in equal quarterly installments over three years following June 2, 2021.
ZIMMER BIOMET HOLDINGS, INC.
Report date May 12, 2017 · Filed May 16, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $121.74 | Direct | 7,810.997 |
Reported balance
After 2017-05-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-05-12 · Grant · Acquired 500 · Balance 7,810.997 F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3: The units are to be settled in shares of Company company stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4: Includes 56.819 phantom stock units accrued between July 29, 2016 and April 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 15,178.577 |
Reported balance
After 2017-05-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-05-12 · Grant · Acquired 1,067.85 · Balance 15,178.577 F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. |
Filing footnotes · ownership attribution and instrument terms
F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3: The units are to be settled in shares of Company company stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units").
F4: Includes 56.819 phantom stock units accrued between July 29, 2016 and April 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F5: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
F6: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date September 01, 2006 · Filed September 08, 2006
Section 16 reporting ended · disclosed 2006-09-08. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2021 Filed Jun 4, 2021 16:05 UTC | KINETA, INC./DE YMTX · Entity 77778 | GrantStock Option (Right to Buy) · Derivative | 14,800 | $0.00 Strike: $15.26 | $0.00 |
DisclosureSEC source: 0000899243-21-022009 · doc4.xml · derivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,800 Underlying: Common Stock · 14,800 shares Expires 2031-06-01 F1 · derivative.exercise_date: The shares subject to the option shall vest in equal quarterly installments over three years following June 2, 2021. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 18:37 UTC | KINETA, INC./DE YMTX · Entity 77778 | GrantCommon Stock | 1,959 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-004741 · doc4.xml · nonDerivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,117 F1 · kind: The shares reported in this transaction represent Restricted Stock Units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in full on February 1, 2022. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 19:15 UTC | KINETA, INC./DE YMTX · Entity 77778 | GrantStock Option (Right to Buy) · Derivative | 5,271 | Not disclosed Strike: $8.16 | Not disclosed |
DisclosureSEC source: 0000899243-20-035278 · doc4.xml · derivative · entry 2 PICKETT CECIL B · CIK 0001238308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,271 Underlying: Common Stock · 5,271 shares Expires 2030-04-06 F1 · date: On August 22, 2020, the Issuer (formerly known as Proteostasis Therapeutics, Inc.) entered into an Agreement and Plan of Merger and Reorganization, as amended on November 6, 2020, with Pangolin Merger Sub, Inc. ("Merger Sub"), Yumanity, Inc. (formerly known as Yumanity Therapeutics, Inc.) and Yumanity Holdings, LLC ("Holdings"). On December 22, 2020, Merger Sub was merged with and into Yumanity, Inc., with Yumanity, Inc. surviving as a wholly-owned subsidiary of the Issuer (the "Merger"). Immediately prior to the consummation of the Merger, Holdings was merged with and into Yumanity, Inc., with Yumanity, Inc. as the surviving entity. F4 · price: Received in the Merger in exchange for a stock option to acquire 25,000 shares of Yumanity, Inc. common stock for $1.72 per share. F3 · derivative.exercise_date: The shares subject to the option vest in equal quarterly installments over four years, commencing on February 18, 2020. Read SEC document |
| December 22, 2020 Filed Dec 28, 2020 19:15 UTC | KINETA, INC./DE YMTX · Entity 77778 | GrantCommon Stock | 6,158 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-035278 · doc4.xml · nonDerivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,158 F1 · date: On August 22, 2020, the Issuer (formerly known as Proteostasis Therapeutics, Inc.) entered into an Agreement and Plan of Merger and Reorganization, as amended on November 6, 2020, with Pangolin Merger Sub, Inc. ("Merger Sub"), Yumanity, Inc. (formerly known as Yumanity Therapeutics, Inc.) and Yumanity Holdings, LLC ("Holdings"). On December 22, 2020, Merger Sub was merged with and into Yumanity, Inc., with Yumanity, Inc. surviving as a wholly-owned subsidiary of the Issuer (the "Merger"). Immediately prior to the consummation of the Merger, Holdings was merged with and into Yumanity, Inc., with Yumanity, Inc. as the surviving entity. F2 · price: The shares were received in exchange for 29,207.50 shares of Yumanity, Inc. common stock in connection with the Merger. Read SEC document |
| May 12, 2017 Filed May 16, 2017 18:10 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,067.85 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-17-000170 · edgar.xml · derivative · entry 2 PICKETT CECIL B · CIK 0001238308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,178.577 Underlying: Common Stock · 1,067.85 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 12, 2017 Filed May 16, 2017 18:10 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $121.74 | $0.00 |
DisclosureSEC source: 0000911916-17-000170 · edgar.xml · derivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,810.997 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company company stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company company stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 56.819 phantom stock units accrued between July 29, 2016 and April 28, 2017 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| August 25, 2006 Filed Aug 29, 2006 14:30 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 100,000 | Not disclosed Strike: $17.00 | Not disclosed |
DisclosureSEC source: 0000310158-06-000100 · pic566.xml · derivative · entry 3 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2006-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Not Applicable. F2 · derivative.exercise_date: These options are currently exercisable. Read SEC document |
| August 25, 2006 Filed Aug 29, 2006 14:30 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 100,000 | $20.10 | $2,010,000.00 |
DisclosureSEC source: 0000310158-06-000100 · pic566.xml · nonDerivative · entry 2 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,541.15 F1 · ownership.direct: Includes stock units acquired pursuant to a dividend reinvestment feature of the Issuer's Profiit Sharing Benefits Equalization Plan as of June 30, 2006. These stock units were credited pursuant to a deferral feature of the plan and are payable upon the reporting person's retirement or other termination of service. Read SEC document |
| August 25, 2006 Filed Aug 29, 2006 14:30 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 100,000 | $17.00 | $1,700,000.00 |
DisclosureSEC source: 0000310158-06-000100 · pic566.xml · nonDerivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,541.15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2006 Filed May 23, 2006 19:04 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 215,000 | Not disclosed Strike: $19.23 | Not disclosed |
DisclosureSEC source: 0000310158-06-000056 · pic538.xml · derivative · entry 2 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Shares · 215,000 shares Expires 2013-05-18 F6 · price: Not Applicable. F5 · derivative.exercise_date: Granted under Schering-Plough Corporation 2006 Stock Incentive Plan and exerciseable in one-third increments on April 1 of 2007, 2008 and 2009. The vesting of 43,000 option shares is subject to Schering-Plough's satisfaction of certain performance criteria for the year 2006. Read SEC document |
| May 19, 2006 Filed May 23, 2006 19:04 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantDeferred Stock Unit Award · Derivative | 35,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-06-000056 · pic538.xml · derivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,616 Underlying: Common Shares · 35,000 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F2 · derivative.exercise_date: Granted under Schering-Plough Corporation 2006 Stock Incentive Plan. All of the shares become deliverable on April 1, 2009 subject to Schering-Plough's satisfaction of certain performance criteria for the year 2006. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 13, 2005 Filed Dec 14, 2005 23:29 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 5,819 | $19.60 | $114,052.40 |
DisclosureSEC source: 0000310158-05-000101 · pic505.xml · nonDerivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,537.96 Read SEC document |
| December 01, 2005 Filed Dec 2, 2005 23:14 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 10,848 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-05-000095 · pic502.xml · derivative · entry 3 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,616 Underlying: Common Shares · 10,848 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2005 Filed Dec 2, 2005 23:14 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 5,029 | $19.05 | $95,802.45 |
DisclosureSEC source: 0000310158-05-000095 · pic502.xml · nonDerivative · entry 2 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,356.96 F2 · balance_after: Includes stock units acquired pursuant to a dividend reinvestment feature of the Issuer's Profiit Sharing Benefits Equalization Plan as of September 30, 2005. These stock units were credited pursuant to a deferral feature of the plan and are payable upon the reporting person's retirement or other termination of service. Read SEC document |
| December 01, 2005 Filed Dec 2, 2005 23:14 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 10,848 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-05-000095 · pic502.xml · nonDerivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,385.96 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| May 04, 2005 Filed May 5, 2005 22:11 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 5,591 | $20.79 | $116,236.89 |
DisclosureSEC source: 0000310158-05-000050 · pic484.xml · nonDerivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,535.98 F1 · balance_after: Includes stock units acquired pursuant to a dividend reinvestment feature of the Issuer's Profiit Sharing Benefits Equalization Plan as of February 28, 2005. These stock units are payable upon the reporting person's retirement or other termination of service. Read SEC document |
| April 25, 2005 Filed Apr 27, 2005 19:53 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 225,000 | Not disclosed Strike: $20.70 | Not disclosed |
DisclosureSEC source: 0000310158-05-000024 · pic478.xml · derivative · entry 2 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Shares · 225,000 shares Expires 2015-04-24 F6 · price: Not Applicable. F5 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on April 26 of each 2006, 2007 and 2008, subject to Schering-Plough's satisfaction of certain performance criteria for the year 2005 with respect to 45,000 option shares. Read SEC document |
| April 25, 2005 Filed Apr 27, 2005 19:53 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantDeferred Stock Unit Award · Derivative | 41,200 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-05-000024 · pic478.xml · derivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,464 Underlying: Common Shares · 41,200 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F2 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan. All of the shares become deliverable on April 25, 2008, subject to Schering-Plough's satisfaction of certain performance criteria for the year 2005 with respect to 40,000 shares. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2004 Filed Dec 3, 2004 18:36 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 10,848 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001223203-04-000267 · pic439.xml · derivative · entry 3 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,264 Underlying: Common Shares · 10,848 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2004 Filed Dec 3, 2004 18:36 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 5,257 | $18.41 | $96,781.37 |
DisclosureSEC source: 0001223203-04-000267 · pic439.xml · nonDerivative · entry 2 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,124.82 F2 · balance_after: Includes stock units acquired pursuant to a dividend reinvestment feature of the Issuer's Profiit Sharing Benefits Equalization Plan as of September 30, 2004. These stock units were credited pursuant to a deferral feature of the plan and are payable upon the reporting person's retirement or other termination of service. Read SEC document |
| December 01, 2004 Filed Dec 3, 2004 18:36 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 10,848 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001223203-04-000267 · pic439.xml · nonDerivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,381.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 20:44 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantPhantom Stock Units · Derivative | 340,508 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000043 · pic369.xml · derivative · entry 4 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,508 Underlying: Common Shares · 340,508 shares Expires not disclosed F8 · derivative.exercise_price: 1 for 1 F10 · price: Not Applicable. F9 · derivative.exercise_date: Includes grants under the Long-Term Performance Share Unit Incentive Plan and the Transformational Performance Contingent Shares Program. The shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer. F9 · derivative.expiration_date: Includes grants under the Long-Term Performance Share Unit Incentive Plan and the Transformational Performance Contingent Shares Program. The shares of phantom stock become payable in cash upon the reporting person's termination of service as an employee of the Issuer. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 20:44 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (Right to Buy) · Derivative | 225,000 | Not disclosed Strike: $18.20 | Not disclosed |
DisclosureSEC source: 0000310158-04-000043 · pic369.xml · derivative · entry 3 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Shares · 225,000 shares Expires 2014-02-22 F7 · price: Not Applicable. F6 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on February 24 of each 2005, 2006 and 2007. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 20:44 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantDeferred Stock Unit Award · Derivative | 40,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000043 · pic369.xml · derivative · entry 2 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,440 Underlying: Common Shares · 40,000 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F5 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan. All of the shares become deliverable on February 23, 2007. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| February 23, 2004 Filed Feb 25, 2004 20:44 UTC | Merck & Co., Inc. SGP · Entity 2807 | OtherDeferred Stock Unit Award · Derivative | 52,360 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000043 · pic369.xml · derivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,440 Underlying: Common Shares · 52,360 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F2 · kind: 16,640 shares vested from the original performance award of 69,000 shares granted on 2/24/2003; unvested shares from original grant forfeited and deducted from total. Twenty percent of the award becomes deliverable annually. F4 · price: Not Applicable. F2 · derivative.exercise_date: 16,640 shares vested from the original performance award of 69,000 shares granted on 2/24/2003; unvested shares from original grant forfeited and deducted from total. Twenty percent of the award becomes deliverable annually. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| February 23, 2004 Filed Mar 15, 2004 16:16 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 3,328 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-04-000048 · pic377.xml · derivative · entry 3 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,112 Underlying: Common Shares · 3,328 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Not Applicable. F5 · price: Not Applicable. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: Not Applicable. Read SEC document |
| February 23, 2004 Filed Mar 15, 2004 16:16 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 1,426 | $18.20 | $25,953.20 |
DisclosureSEC source: 0000310158-04-000048 · pic377.xml · nonDerivative · entry 2 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,529.21 Read SEC document |
| February 23, 2004 Filed Mar 15, 2004 16:16 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 3,328 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-04-000048 · pic377.xml · nonDerivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,955.21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| December 02, 2003 Filed Dec 3, 2003 17:00 UTC | Merck & Co., Inc. SGP · Entity 2807 | SaleCommon Shares | 37,000 | $16.67 | $616,790.00 |
DisclosureSEC source: 0000310158-03-000147 · pic303.xml · nonDerivative · entry 3 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,627.21 F2 · balance_after: Includes stock units acquired pursuant to a dividend reinvestment feature of the Issuer's Profiit Sharing Benefits Equalization Plan as of September 16, 2003. These stock units were credited pursuant to a deferral feature of the plan and are payable upon the reporting person's retirement or other termination of service. Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 17:00 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 18,800 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-03-000147 · pic303.xml · derivative · entry 4 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,800 Underlying: Common Shares · 18,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Not Applicable. F6 · price: Not Applicable. F4 · derivative.exercise_date: Not Applicable. F5 · derivative.expiration_date: Not Applicable. Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 17:00 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 8,054 | $16.63 | $133,938.02 |
DisclosureSEC source: 0000310158-03-000147 · pic303.xml · nonDerivative · entry 2 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,627.21 Read SEC document |
| December 01, 2003 Filed Dec 3, 2003 17:00 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 18,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000310158-03-000147 · pic303.xml · nonDerivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,681.21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| September 16, 2003 Filed Sep 18, 2003 19:47 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionOption (right to buy) · Derivative | 110,000 | $0.00 Strike: $8.30 | $0.00 |
DisclosureSEC source: 0000310158-03-000073 · pic214.xml · derivative · entry 3 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 110,000 shares Expires 2003-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted under the Schering-Plough Corporation 1992 Stock Incentive Plan. F3 · derivative.exercise_date: These options are currently exercisable. Read SEC document |
| September 16, 2003 Filed Sep 18, 2003 19:47 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 38,160 | $16.08 | $613,612.80 |
DisclosureSEC source: 0000310158-03-000073 · pic214.xml · nonDerivative · entry 2 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,881.21 F1 · balance_after: Includes 13.04 stock units acquired pursuant to a dividend reinvestment feature of the Issuer's Profit Sharing Benefits Equalization Plan as of September 16, 2003. These stock units were credited pursuant to a deferral feature of the plan and are payble upon the reporting person's retirement or other termination of service. Read SEC document |
| September 16, 2003 Filed Sep 18, 2003 19:47 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 110,000 | $8.30 | $913,000.00 |
DisclosureSEC source: 0000310158-03-000073 · pic214.xml · nonDerivative · entry 1 PICKETT CECIL B · CIK 0001238308 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,041.21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.